Literature DB >> 17015724

Somatic hypermutation and class switch recombination in Msh6(-/-)Ung(-/-) double-knockout mice.

Hong Ming Shen1, Atsushi Tanaka, Grazyna Bozek, Dan Nicolae, Ursula Storb.   

Abstract

Somatic hypermutation (SHM) and class switch recombination (CSR) are initiated by activation-induced cytosine deaminase (AID). The uracil, and potentially neighboring bases, are processed by error-prone base excision repair and mismatch repair. Deficiencies in Ung, Msh2, or Msh6 affect SHM and CSR. To determine whether Msh2/Msh6 complexes which recognize single-base mismatches and loops were the only mismatch-recognition complexes required for SHM and CSR, we analyzed these processes in Msh6(-/-)Ung(-/-) mice. SHM and CSR were affected in the same degree and fashion as in Msh2(-/-)Ung(-/-) mice; mutations were mostly C,G transitions and CSR was greatly reduced, making Msh2/Msh3 contributions unlikely. Inactivating Ung alone reduced mutations from A and T, suggesting that, depending on the DNA sequence, varying proportions of A,T mutations arise by error-prone long-patch base excision repair. Further, in Msh6(-/-)Ung(-/-) mice the 5' end and the 3' region of Ig genes was spared from mutations as in wild-type mice, confirming that AID does not act in these regions. Finally, because in the absence of both Ung and Msh6, transition mutations from C and G likely are "footprints" of AID, the data show that the activity of AID is restricted drastically in vivo compared with AID in cell-free assays.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015724     DOI: 10.4049/jimmunol.177.8.5386

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

Review 1.  Does DNA repair occur during somatic hypermutation?

Authors:  Huseyin Saribasak; Patricia J Gearhart
Journal:  Semin Immunol       Date:  2012-06-22       Impact factor: 11.130

2.  Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias.

Authors:  Zheng Xiao; Madhumita Ray; Chuancang Jiang; Alan B Clark; Igor B Rogozin; Marilyn Diaz
Journal:  Mol Immunol       Date:  2007-01-22       Impact factor: 4.407

3.  p21 is dispensable for AID-mediated class switch recombination and mutagenesis of immunoglobulin genes during somatic hypermutation.

Authors:  Maryam Shansab; Erik Selsing
Journal:  Mol Immunol       Date:  2011-02-01       Impact factor: 4.407

4.  AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.

Authors:  Xiwen Gu; Carmen J Booth; Zongzhi Liu; Matthew P Strout
Journal:  Blood       Date:  2015-09-18       Impact factor: 22.113

5.  Characterization of DNA glycosylase activity by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Agus Darwanto; Alvin Farrel; Daniel K Rogstad; Lawrence C Sowers
Journal:  Anal Biochem       Date:  2009-07-14       Impact factor: 3.365

6.  MSH2/MSH6 complex promotes error-free repair of AID-induced dU:G mispairs as well as error-prone hypermutation of A:T sites.

Authors:  Sergio Roa; Ziqiang Li; Jonathan U Peled; Chunfang Zhao; Winfried Edelmann; Matthew D Scharff
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

7.  The activation-induced cytidine deaminase (AID) efficiently targets DNA in nucleosomes but only during transcription.

Authors:  Hong Ming Shen; Michael G Poirier; Michael J Allen; Justin North; Ratnesh Lal; Jonathan Widom; Ursula Storb
Journal:  J Exp Med       Date:  2009-04-20       Impact factor: 14.307

8.  Dependence of nucleotide substitutions on Ung2, Msh2, and PCNA-Ub during somatic hypermutation.

Authors:  Peter H L Krijger; Petra Langerak; Paul C M van den Berk; Heinz Jacobs
Journal:  J Exp Med       Date:  2009-11-09       Impact factor: 14.307

9.  Attracting AID to targets of somatic hypermutation.

Authors:  Atsushi Tanaka; Hong Ming Shen; Sarayu Ratnam; Prashant Kodgire; Ursula Storb
Journal:  J Exp Med       Date:  2010-01-25       Impact factor: 14.307

10.  Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID.

Authors:  Meng Wang; Cristina Rada; Michael S Neuberger
Journal:  J Exp Med       Date:  2010-01-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.